GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Net Margin %

Mega Lifesciences PCL (BKK:MEGA-R) Net Margin % : 14.02% (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Mega Lifesciences PCL's Net Income for the three months ended in Mar. 2025 was ฿450 Mil. Mega Lifesciences PCL's Revenue for the three months ended in Mar. 2025 was ฿3,208 Mil. Therefore, Mega Lifesciences PCL's net margin for the quarter that ended in Mar. 2025 was 14.02%.

The historical rank and industry rank for Mega Lifesciences PCL's Net Margin % or its related term are showing as below:

BKK:MEGA-R' s Net Margin % Range Over the Past 10 Years
Min: 8.76   Med: 11.72   Max: 14.29
Current: 13.39


BKK:MEGA-R's Net Margin % is ranked better than
77.07% of 968 companies
in the Drug Manufacturers industry
Industry Median: 4.93 vs BKK:MEGA-R: 13.39

Mega Lifesciences PCL Net Margin % Historical Data

The historical data trend for Mega Lifesciences PCL's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Net Margin % Chart

Mega Lifesciences PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.06 13.77 14.29 12.71 13.12

Mega Lifesciences PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.80 12.97 9.56 17.48 14.02

Competitive Comparison of Mega Lifesciences PCL's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Lifesciences PCL's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's Net Margin % distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's Net Margin % falls into.


;
;

Mega Lifesciences PCL Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Mega Lifesciences PCL's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=2012.481/15344.136
=13.12 %

Mega Lifesciences PCL's Net Margin for the quarter that ended in Mar. 2025 is calculated as

Net Margin=Net Income (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=449.836/3207.676
=14.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mega Lifesciences PCL  (BKK:MEGA-R) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Mega Lifesciences PCL Net Margin % Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL Business Description

Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines